This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Breakout Stocks: SPDR Gold Trust, Netflix

One final stock that is starting to breakout is DexCom (DXCM - Get Report). This company focuses on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by health care providers in the hospital for the treatment of both diabetic and non-diabetic patients.

On Aug. 3, DexCom reported that product revenue grew by around $9 million for the second-quarter of 2010, which was an increase of about 120% from the $4.1 million it reported for the second-quarter of 2009. Total second-quarter revenue for 2010 also grew by 75% from the same quarter in 2009, and an increase of around 23% from the first quarter of 2010.

These strong fundamental results for DexCom helped to push the stock up towards new 52-week highs, which it hit last week when the shares traded at $12.68. This move is coming on above average volume with a number of up days last week trading at well over the 3-month average daily volume of 375,000 shares.

DexCom shares officially broke out in the near term when the stock was able to get above $12.35. The next area of significant resistance sits at around $15, which the stock last traded at back in 2006.

I think there is a strong chance DexCom trades back towards $15 and if it can manage to take out that level, it could quickly move into the low $20s. One of the reasons I think DexCom could trade significant higher is due to the reasonable short interest of 7% and a very low tradable float of 52 million shares.

If the good fundamental news for DexCom continues, then the stock should short squeeze and reach some of my targets mentioned above.

-- Written by Roberto Pedone in Winderemere, Fla.
Stockpickr is a wholly owned subsidiary of
4 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ATHN $133.07 -4.20%
DXCM $64.05 -2.90%
GOL $6.90 -0.43%
NFLX $89.61 -0.74%
SO $49.48 -0.94%


Chart of I:DJI
DOW 17,705.02 -125.74 -0.71%
S&P 500 2,062.01 -13.80 -0.66%
NASDAQ 4,776.0730 -29.2180 -0.61%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs